NCT00920296View on ClinicalTrials.gov

DDI Study of Etravirine and GSK1265744

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions

Healthy SubjectsInfection, Human Immunodeficiency Virus

Interventions

DRUG

GSK1265744

GSK drug

Trial Locations (1)

78217

GSK Investigational Site, San Antonio

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY